Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The human C3b receptor (CR1).

L Weiss1, E Fischer, N Haeffner-Cavaillon

  • 1Unité d'Immunopathologie, Hôpital Broussais, Paris, France.

Advances in Nephrology From the Necker Hospital
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Tumour of the choroid with yellowish subretinal deposits].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2003
Same author

Hand-assisted laparoscopic splenectomy for giant spleens.

Surgical endoscopy·2003
Same author

Coronary artery bypass grafting supported with intracardiac microaxial pumps versus normothermic cardiopulmonary bypass: a prospective randomized trial.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2002
Same author

Inhibition of fusion of Chlamydia trachomatis inclusions at 32 degrees C correlates with restricted export of IncA.

Infection and immunity·2002
Same author

One-year survival and neurological outcome after pediatric cardiopulmonary resuscitation.

Intensive care medicine·2002
Same author

Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets.

British journal of pharmacology·2001

The human complement system, crucial for immunity, uses proteins like C3b to tag pathogens for destruction. Its receptor, CR1, aids immune complex processing and phagocytosis, but its expression decreases in SLE and HIV patients.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • The human complement system involves 19 plasma proteins and 9 cellular receptors, playing a vital role in host defense against infections.
  • Complement activation generates ligands that interact with cellular receptors, mediating effects like opsonization, cell lysis, and inflammatory mediator release.
  • Key complement proteins include C3, C3a (anaphylatoxin), and C3b, which covalently binds to targets and serves as a ligand for the C3b receptor, CR1 (CD 35).

Purpose of the Study:

  • To elucidate the functions of the human complement system, particularly the role of C3b and its receptor CR1.
  • To understand how complement activation fragments interact with cellular receptors to mediate biological effects.
  • To investigate the clinical relevance of CR1 expression, noting its decrease in systemic lupus erythematosus (SLE) and human immunodeficiency virus (HIV) infections.

Related Experiment Videos

Main Methods:

  • Review of complement system components and their functions.
  • Analysis of ligand-receptor interactions in complement activation.
  • Examination of CR1 (CD 35) expression and its association with immune processes and diseases.

Main Results:

  • Complement activation produces soluble (e.g., C3a, C5a) and bifunctional ligands (e.g., C3b).
  • Surface-bound C3b acts as a ligand for CR1 on peripheral blood cells, facilitating immune complex processing, microbial phagocytosis, and immune response regulation.
  • CR1 cellular expression is reduced in patients with SLE and HIV.

Conclusions:

  • The complement system, through C3b and CR1 interactions, is essential for effective host defense and immune regulation.
  • CR1 plays a significant role in clearing pathogens and immune complexes.
  • Decreased CR1 expression in SLE and HIV suggests a link between complement dysregulation and these diseases.